Meihua International Medical Technologies Co Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $2.4
- Today's High:
- $2.5599
- Open Price:
- $2.41
- 52W Low:
- $2.294
- 52W High:
- $45.49
- Prev. Close:
- $2.4
- Volume:
- 4622
Company Statistics
- Market Cap.:
- $64.64 million
- Book Value:
- 5.77
- Revenue TTM:
- $103.35 million
- Operating Margin TTM:
- 15.05%
- Gross Profit TTM:
- $37.97 million
- Profit Margin:
- 6.04%
- Return on Assets TTM:
- 6.47%
- Return on Equity TTM:
- 5.01%
Company Profile
Meihua International Medical Technologies Co Ltd had its IPO on 2022-02-16 under the ticker symbol MHUA.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Meihua International Medical Technologies Co Ltd has a staff strength of 626 employees.
Stock update
Shares of Meihua International Medical Technologies Co Ltd opened at $2.41 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $2.4 - $2.56, and closed at $2.56.
This is a +6.66% increase from the previous day's closing price.
A total volume of 4,622 shares were traded at the close of the day’s session.
In the last one week, shares of Meihua International Medical Technologies Co Ltd have slipped by -8.58%.
Meihua International Medical Technologies Co Ltd's Key Ratios
Meihua International Medical Technologies Co Ltd has a market cap of $64.64 million, indicating a price to book ratio of 1.4505 and a price to sales ratio of 1.7786.
In the last 12-months Meihua International Medical Technologies Co Ltd’s revenue was $103.35 million with a gross profit of $37.97 million and an EBITDA of $16.12 million. The EBITDA ratio measures Meihua International Medical Technologies Co Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Meihua International Medical Technologies Co Ltd’s operating margin was 15.05% while its return on assets stood at 6.47% with a return of equity of 5.01%.
In Q2, Meihua International Medical Technologies Co Ltd’s quarterly earnings growth was a negative -37% while revenue growth was a negative 12.9%.
Meihua International Medical Technologies Co Ltd’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 10.3846
- PEG
Its diluted EPS in the last 12-months stands at $0.26 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Meihua International Medical Technologies Co Ltd’s profitability.
Meihua International Medical Technologies Co Ltd stock is trading at a EV to sales ratio of 1.6039 and a EV to EBITDA ratio of 7.3959. Its price to sales ratio in the trailing 12-months stood at 1.7786.
Meihua International Medical Technologies Co Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $163.58 million
- Total Liabilities
- $24.17 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
Meihua International Medical Technologies Co Ltd ended 2024 with $163.58 million in total assets and $0 in total liabilities. Its intangible assets were valued at $163.58 million while shareholder equity stood at $138.12 million.
Meihua International Medical Technologies Co Ltd ended 2024 with $0 in deferred long-term liabilities, $24.17 million in other current liabilities, 11970.00 in common stock, $83.33 million in retained earnings and $0 in goodwill. Its cash balance stood at $26.74 million and cash and short-term investments were $26.74 million. The company’s total short-term debt was $6,089,428 while long-term debt stood at $0.
Meihua International Medical Technologies Co Ltd’s total current assets stands at $135.32 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $91.03 million compared to accounts payable of $16.10 million and inventory worth $1.12 million.
In 2024, Meihua International Medical Technologies Co Ltd's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, Meihua International Medical Technologies Co Ltd paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $2.56
- 52-Week High
- $45.49
- 52-Week Low
- $2.294
- Analyst Target Price
- $
Meihua International Medical Technologies Co Ltd stock is currently trading at $2.56 per share. It touched a 52-week high of $45.49 and a 52-week low of $45.49. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $2.86 and 200-day moving average was $8.18 The short ratio stood at 0.13 indicating a short percent outstanding of 0%.
Around 6656.2% of the company’s stock are held by insiders while 34.6% are held by institutions.
Frequently Asked Questions About Meihua International Medical Technologies Co Ltd
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People’s Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People’s Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.